SCHEMBL9643573

SCHEMBL9643573

CC(=O)Oc1c(Oc2ccccc2)c(Oc2ccccc2)c(OC(=O)CC(C)C)c2ccc(Cl)cc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB11 O95342 1/20 0.53
MAPT P10636 5/20 0.38
LMNA P02545 5/20 0.38
KDM4E B2RXH2 4/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
ALDH1A1 P00352 3/20 0.38
HPGD P15428 2/20 0.38
GAA P10253 2/20 0.38
MPI P34949 1/20 0.38
TSPO P30536 1/20 0.37
HTT P42858 5/20 0.36
POLB P06746 4/20 0.36
RECQL P46063 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
FFAR1 O14842 1/20 0.36
BACE1 P56817 1/20 0.35
PTGES2 Q9H7Z7 1/20 0.35
DHODH Q02127 1/20 0.35
KMT2A Q03164 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9642908 1.00 ABCB11 (0.53) ABCB11MAPTLMNAKDM4ESMN1; SMN2
SCHEMBL9642959 0.88 ABCB11 (0.67) ABCB11MAPTLMNAKDM4ESMN1; SMN2
SCHEMBL9642915 0.85 ABCB11 (0.49) ABCB11MAPTLMNAKDM4ESMN1; SMN2
SCHEMBL29371419 0.83 ABCB11 (0.48) ABCB11MAPTLMNASMN1; SMN2ALDH1A1
SCHEMBL9642718 0.82 ABCB11 (0.48) ABCB11MAPTLMNAKDM4ESMN1; SMN2
SCHEMBL9643961 0.81 ABCB11 (0.57) ABCB11MAPTLMNAKDM4ESMN1; SMN2
SCHEMBL9642545 0.81 ABCB11 (0.57) ABCB11MAPTLMNAKDM4ESMN1; SMN2
SCHEMBL9643876 0.81 ABCB11 (0.47) ABCB11MAPTLMNAKDM4ESMN1; SMN2
SCHEMBL9643182 0.81 ABCB11 (0.54) ABCB11MAPTLMNAKDM4ESMN1; SMN2
SCHEMBL9642245 0.81 ABCB11 (0.54) ABCB11MAPTLMNAKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0215622-B1 NAPHTHALENE ANTI-PSORIATIC AGENTS AND PROCESS FOR MAKING THEM SYNTEX (U.S.A.) INC. (US) 1992-06-17 EP disclosed
US-4946845-A STABLE ANTIINFLAMMATORY AGENTS, LIPOXYGENASE INHIBITORS SYNTEX (U.S.A.) INC. (US) 1990-08-07 US disclosed
US-4792556-A LIPOXYGENASE INHIBITORS SYNTEX (U.S.A.) INC. (US) 1988-12-20 US disclosed
EP-0215622-A2 Naphthalene anti-psoriatic agents and process for making them SYNTEX (U.S.A.) INC. (US) 1987-03-25 EP disclosed